|
Previous Study | Return to Search Results | Next Study |
|
|
|
|
|
Sponsors and Collaborators: |
Shalvata Mental Health Center Brainsway |
Information provided by: | Shalvata Mental Health Center |
ClinicalTrials.gov Identifier: | NCT00445237 |
This study is evaluating the safety and feasibility of the novel deep TMS H-coil designs in the treatment of resistant major depression in an open study using two different H-coil designs.
Condition | Intervention | Phase |
Major Depression |
Device: H1 and H2 deep TMS coils |
Phase I |
MedlinePlus related topics: | Depression |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Uncontrolled, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Evaluation of the H1 Coil and H2 Coil TMS Device - Safety and Feasibility in Major Depression Episode |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Eiran V Harel | 972-9-7478644 | evharel@clalit.org.il |
Israel | |||||
Shalvata MHC | Recruiting | ||||
Hod Hasharon, Israel |
Shalvata Mental Health Center |
Brainsway |
Principal Investigator: | Hilik Levkovits | Day care hospital director |
Study ID Numbers: | SH-505 |
First Received: | March 7, 2007 |
Last Updated: | March 7, 2007 |
ClinicalTrials.gov Identifier: | NCT00445237 |
Health Authority: | Israel: Ministry of Health |
|
|
|